There’s some promising news for people living with myelodysplastic syndrome (MDS) as a new treatment option may reduce the ...

Myelodysplastic syndrome (MDS) comprises a group of clonal bone marrow disorders characterized by ineffective hematopoiesis and increased predisposition to acute myeloid leukemia. The causes of ...

Manjit Kooner's journey with Myelodysplastic Syndrome (MDS) has been a challenging one, marked by strength, resilience, and ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Myelodysplastic syndrome (MDS) can be difficult to diagnose. Many people who are diagnosed with MDS go to their doctor with some or all of the symptoms typical of MDS. Other people are diagnosed with ...

Saeed Sadeghi, MD, discusses the findings on transfusion independence achieved with treatment for patients with low-risk myelodysplastic syndrome.

A steam locomotive, which has been restored in memory of a boy from Plymstock, has made its maiden voyage. The 'Lord Oliver ...

The new findings are the first to describe distributions and perturbations of low-density granulocyte and normal-density neutrophil subsets in myelodysplastic syndromes (MDS), acute myeloid leukemia ...

For information, the company have announced that the STIMULUS program for Sabatolimab with azacitidine for untreated high-risk myelodysplastic syndromes has been terminated and therefore they will no ...

A multimodal computational framework for patient stratification and prognosis prediction enables automatic identification of patient clusters, outperforming classical approaches for patients with ...

Rigel Therapeutics expands oncology portfolio with REZLIDHIA & GAVRETO, sees promising R289 results. Click here to read my ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...